Asymmetric dimethylarginine-d7 (hydrochloride hydrate)
CAT:
804-HY-113216S-02
Size:
5 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
Asymmetric dimethylarginine-d7 (hydrochloride hydrate)
- UNSPSC Description: Asymmetric dimethylarginine-d7 (hydrochloride hydrate) is the deuterium labeled Asymmetric dimethylarginine. Asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthase (NOS), and functions as a marker of endothelial dysfunction in a num
- Target Antigen: Endogenous Metabolite; Isotope-Labeled Compounds; NO Synthase
- Type: Isotope-Labeled Compounds
- Related Pathways: Immunology/Inflammation;Metabolic Enzyme/Protease;Others
- Field of Research: Cardiovascular Disease; Cancer
- Assay Protocol: https://www.medchemexpress.com/asymmetric-dimethylarginine-d7-hydrochloride-hydrate.html
- Solubility: 10 mM in DMSO
- Smiles: CN(C)C(NC([2H])([2H])C([2H])([2H])C([2H])([2H])C(N)([2H])C(O)=O)=N.Cl.[xH2O]
- References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.|[2]Hudson CL, et al. The cardiovascular risk marker asymmetric dimethylarginine is elevated in asymptomatic, untreated HIV-1 infection and correlates with markers of immune activation and disease progression. Ann Clin Biochem. 2014 Sep;51(Pt 5):568-75.
- Shipping Conditions: Room temperature
- Clinical Information: No Development Reported